Regulations.gov document

[TAB 51] Schnitzer et al., Preferential interaction of albumin-binding proteins, gp30 and…

Supporting & Related Material · FDA-2015-P-0732 · posted Mar 10, 2015

Key facts

Document ID FDA-2015-P-0732-0055
Title [TAB 51] Schnitzer et al., Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism. J Biol Chem, 1992; 267:24544-24553. Citizen Petition From Celgene (Arnold and Porter)
Document type Supporting & Related Material
Subtype Published Study
Agency FDA
Docket FDA-2015-P-0732
Posted Mar 10, 2015

At a glance

  • 10–99 Public comments on this docket

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Regulations.gov documents

Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.

Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date:

Browse all Regulations.gov documents